Interleukin-2 receptor-α proximal promoter hypomethylation is associated with multiple sclerosis

J. Field, A. Fox, M. A. Jordan, A. G. Baxter, T. Spelman, Melissa M Gresle, H. Butzkueven, Trevor J Kilpatrick, J. P. Rubio

Research output: Contribution to journalArticleResearchpeer-review

21 Citations (Scopus)


Genetic studies have demonstrated association between single-nucleotide polymorphisms within the IL2RA (interleukin-2 receptor α-subunit) gene and risk of developing multiple sclerosis (MS); however, these variants do not have obvious functional consequences. DNA methylation is a source of genetic variation that could impact on autoimmune disease risk. We investigated DNA methylation of the IL2RA promoter in genomic DNA obtained from peripheral blood mononuclear cells and neural tissue using matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) mass spectrometry. A differential methylation profile of IL2RA was identified, suggesting that IL2RA expression was regulated by DNA methylation. We extended our analysis of DNA methylation to peripheral blood mononuclear cell (PBMC) of MS cases and controls using MALDI-TOF and Illumina HumanMethylation450 arrays. Analyses of CpG sites within the proximal promoter of IL2RA in PBMC showed no differences between MS cases and controls despite an increase in IL2RA expression. In contrast, we inferred significant DNA methylation differences specific to particular leukocyte subtypes in MS cases compared with controls by deconvolution of the array data. The decrease in methylation in patients correlated with an increase in IL2RA expression in T cells from MS cases in comparison with controls. Our data suggest that differential methylation of the IL2RA promoter in T cells could be an important pathogenic mechanism in MS.

Original languageEnglish
Pages (from-to)59-66
Number of pages8
JournalGenes and Immunity
Issue number2
Publication statusPublished - 1 Mar 2017
Externally publishedYes

Cite this